GI Dynamics Goes Down Under To Fund First Endoscopic Treatment For Diabetes
This article was originally published in The Gray Sheet
Executive Summary
The Massachusetts-based developer of the EndoBarrier device is leveraging its presence on the Australian stock exchange to finance its drug-like clinical development changes.